You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 23, December 21, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Men's Health
 •Prostate Disease
 •Oncology
 •Prostate Cancer
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mortality Following Prostate Cancer Recurrence After Radical Prostectomy—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Dr Trainer raises questions related to the differences between biopsy-derived and prostatectomy-derived Gleason scores in our study. The pathological specimens, from both biopsy and radical prostatectomy, were read by the same team of pathologists during the entire study period, not by a single pathologist. However, we agree that differences between biopsy and radical prostatectomy grading are well documented.1-2

We believe that the most likely reason is not the pathologist but rather the limited sampling obtained during biopsy in which only a small number of biopsy cores (6 to 12 from contemporary series, fewer in earlier years) are obtained for examination. This provides very limited tissue for examination, and it is not uncommon to miss higher-grade cancer in the biopsy specimen due to this limited sampling. The role of sampling error is further suggested by a recent study that found that obtaining more biopsy cores (more tissue for the . . . [Full Text of this Article]

Stephen J. Freedland, MD
sfreedl1@jhmi.edu

Elizabeth B. Humphreys, BS; Leslie A. Mangold, MS; Alan W. Partin, MD, PhD
Department of Urology

Mario Eisenberger, MD
Department of Urology and Oncology
The James Buchanan Brady Urological Institute
The Johns Hopkins Medical Institution
Baltimore, Md

Frederick J. Dorey, PhD
The Biostatistics Core
University of Southern California Keck School of Medicine
Childrens Hospital Los Angeles
Los Angeles



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Mortality Following Prostate Cancer Recurrence After Radical Prostectomy

JAMA. ;294():2969-2969.
FULL TEXT  

Risk of Prostate Cancer-Specific Mortality Following Biochemical Recurrence After Radical Prostatectomy
, , , , , , and
JAMA. ;294():433-439.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.